Microbiome Therapeutics Market Players:
- YSOPIA Bioscience
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- 4D pharma plc
- Enterome
- BiomX Inc.
- Ferring International Center S.A.
- Vedanta Biosciences, Inc.
- Seres Therapeutics, Inc.
- Assembly Biosciences, Inc.
- Synlogic
- Finch Therapeutics Group, Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of microbiome therapeutics is assessed at USD 695.1 million.
The global microbiome therapeutics market size was valued at more than USD 526.07 million in 2025 and is expected to register a CAGR of over 35.7%, exceeding USD 11.14 billion revenue by 2035.
North America microbiome therapeutics market will hold around 40% share by 2035, driven by the presence of numerous established research facilities for novel therapeutics, rising healthcare expenditure, and an increasingly health-conscious population.
Key players in the market include YSOPIA Bioscience, 4D pharma plc, Enterome, BiomX Inc., Ferring International Center S.A., Vedanta Biosciences, Inc., Seres Therapeutics, Inc., Assembly Biosciences, Inc., Synlogic, Finch Therapeutics Group, Inc.
